At present, there are more than 3 million confirmed patients with Parkinson's disease in China, and it is estimated that the number will be close to 5 million by 23. "Xi Ning" is a commonly used drug for treating Parkinson's disease, and it is the exclusive variety of Merck of the United States.
"Xining" was produced in Merck's Italian factory, then imported into China and repackaged by Merck's Hangzhou factory.
because of its unique composition, there is no other drug that can completely replace it.
As a pharmaceutical company with conscience, Merck has a long tradition. George Merck, the head of this company, once said: "We should remember that drugs are produced for human beings, not for the pursuit of profit."
Merck has made many contributions silently and is a respectable pharmaceutical company.
In China, the first dose of hepatitis B vaccine given to every child after birth is produced by patented technology transferred by Merck for one dollar.
according to the statistics of China health department, from 1984 to 1987, about 12 million people were infected with hepatitis B virus every year, accounting for 1.1% of the total population. At that time, nearly one-tenth of the 2 million newborns born every year were infected with hepatitis B virus.
In p>1988, the government of China hoped to introduce hepatitis B vaccine from Merck, USA. When the government of China just went to the United States to talk about the introduction of hepatitis B vaccine, Merck originally wanted to sell the vaccine directly to the government of China. As a big country with hepatitis B, what a big market China has to be.
But talking about Merck found that the universal medical immunization system in China was still very imperfect at that time, and hepatitis B vaccine was not a free vaccination program in China, so ordinary people could not afford it.